Felice Nava

3.0k total citations · 1 hit paper
65 papers, 2.5k citations indexed

About

Felice Nava is a scholar working on Epidemiology, Cellular and Molecular Neuroscience and Pharmacology. According to data from OpenAlex, Felice Nava has authored 65 papers receiving a total of 2.5k indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Epidemiology, 16 papers in Cellular and Molecular Neuroscience and 14 papers in Pharmacology. Recurrent topics in Felice Nava's work include Hepatitis C virus research (12 papers), Neuroscience and Neuropharmacology Research (11 papers) and Cannabis and Cannabinoid Research (9 papers). Felice Nava is often cited by papers focused on Hepatitis C virus research (12 papers), Neuroscience and Neuropharmacology Research (11 papers) and Cannabis and Cannabinoid Research (9 papers). Felice Nava collaborates with scholars based in Italy, United Kingdom and United States. Felice Nava's co-authors include Fernando Rodrı́guez de Fonseca, Daniele Piomelli, Raquel Gómez de Heras, Andrea Giuffrida, Gian Luigi Gessa, Jin Fu, Silvana Gaetani, Eric Murillo‐Rodríguez, Jesse LoVerme and Miguel Navarro and has published in prestigious journals such as Nature, Journal of Neuroscience and Brain Research.

In The Last Decade

Felice Nava

55 papers receiving 2.4k citations

Hit Papers

An anorexic lipid mediator regulated by feeding 2001 2026 2009 2017 2001 100 200 300 400 500

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Felice Nava Italy 26 1.2k 742 443 381 380 65 2.5k
Adele Romano Italy 32 855 0.7× 636 0.9× 653 1.5× 495 1.3× 494 1.3× 76 2.4k
Yosefa Avraham Israel 27 724 0.6× 407 0.5× 502 1.1× 375 1.0× 330 0.9× 54 1.8k
Fabio Arturo Iannotti Italy 30 1.6k 1.3× 707 1.0× 619 1.4× 209 0.5× 882 2.3× 71 2.8k
Kiran Vemuri United States 32 1.9k 1.6× 1.4k 1.9× 445 1.0× 257 0.7× 507 1.3× 70 2.7k
Neta Rimmerman United States 22 1.5k 1.3× 608 0.8× 269 0.6× 165 0.4× 561 1.5× 28 2.8k
Francisco Javier Pavón Spain 34 1.7k 1.5× 1.3k 1.8× 662 1.5× 298 0.8× 914 2.4× 147 4.0k
Daniele De Filippis Italy 30 2.2k 1.9× 864 1.2× 604 1.4× 152 0.4× 654 1.7× 41 3.3k
Ildikó Rácz Hungary 20 1.2k 1.0× 837 1.1× 332 0.7× 120 0.3× 531 1.4× 51 2.4k
Emma Leishman United States 24 887 0.8× 456 0.6× 254 0.6× 203 0.5× 303 0.8× 51 1.8k
Nathan K. Evanson United States 16 1.1k 0.9× 398 0.5× 381 0.9× 299 0.8× 387 1.0× 29 2.8k

Countries citing papers authored by Felice Nava

Since Specialization
Citations

This map shows the geographic impact of Felice Nava's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Felice Nava with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Felice Nava more than expected).

Fields of papers citing papers by Felice Nava

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Felice Nava. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Felice Nava. The network helps show where Felice Nava may publish in the future.

Co-authorship network of co-authors of Felice Nava

This figure shows the co-authorship network connecting the top 25 collaborators of Felice Nava. A scholar is included among the top collaborators of Felice Nava based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Felice Nava. Felice Nava is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Nava, Felice, Alessandra Mangia, Lorenzo Somaini, et al.. (2023). Analysis of Patients’ Characteristics and Treatment Profile of People Who Use Drugs (PWUDs) with and without a Co-Diagnosis of Viral Hepatitis C: A Real-World Retrospective Italian Analysis. Therapeutics and Clinical Risk Management. Volume 19. 645–656. 1 indexed citations
3.
Kondili, Loreta A., Lucia Craxì, Felice Nava, et al.. (2023). From Prioritization to Universal Treatment: Successes and Challenges of Hepatitis C Virus Elimination in Italy. The Journal of Infectious Diseases. 228(Supplement_3). S211–S220. 7 indexed citations
4.
Andreoni, Massimo, Nicola Coppola, Antonio Craxı̀, et al.. (2022). Meet–Test–Treat for HCV management: patients’ and clinicians’ preferences in hospital and drug addiction services in Italy. BMC Infectious Diseases. 22(1). 3–3. 4 indexed citations
5.
Lazarus, Jeffrey V., Camila A Picchio, Soo Aleman, et al.. (2021). Hepatitis C standards of care: A review of good practices since the advent of direct-acting antiviral therapy. Clinics and Research in Hepatology and Gastroenterology. 45(2). 101564–101564. 13 indexed citations
6.
Kondili, Loreta A., Alessio Aghemo, Massimo Andreoni, et al.. (2021). Milestones to reach Hepatitis C Virus (HCV) elimination in Italy: From free-of-charge screening to regional roadmaps for an HCV-free nation. Digestive and Liver Disease. 54(2). 237–242. 19 indexed citations
7.
Testoni, Ines, et al.. (2019). Prisoners’ ambivalent sexism and domestic violence: a narrative study. International Journal of Prisoner Health. ahead-of-print(ahead-of-print). 332–348. 11 indexed citations
9.
Nava, Felice, A. Albertí, Massimo Andreoni, et al.. (2018). For a program of eradication of hepatitis C in the populations at risk (drug users and convicts). PubMed Central. 3 indexed citations
11.
Monarca, Roberto, Giordano Madeddu, Roberto Ranieri, et al.. (2015). HIV treatment and care among Italian inmates: a one-month point survey. BMC Infectious Diseases. 15(1). 562–562. 12 indexed citations
12.
Nava, Felice, et al.. (2009). New Frontiers in Alcoholism and Addiction Treatment. PubMed. 5(1). 81–94. 3 indexed citations
13.
Nava, Felice, et al.. (2007). Chronic cannabis use does not affect the normalization of hypothalamic–pituitary–adrenal (HPA) axis induced by methadone in heroin addicts. Progress in Neuro-Psychopharmacology and Biological Psychiatry. 31(5). 1089–1094. 14 indexed citations
14.
Nava, Felice, et al.. (2006). Relationship Between Plasma Cortisol Levels, Withdrawal Symptoms and Craving in Abstinent and Treated Heroin Addicts. Journal of Addictive Diseases. 25(2). 9–16. 40 indexed citations
15.
Nava, Felice, Giovanna Carta, & Gian Luigi Gessa. (2000). Permissive Role of Dopamine D2 Receptors in the Hypothermia Induced by Δ9-Tetrahydrocannabinol in Rats. Pharmacology Biochemistry and Behavior. 66(1). 183–187. 43 indexed citations
16.
Nava, Felice & Achille P. Caputi. (1999). Central effects of cromoglycate sodium salt in rats treated with lipopolysaccharide. European Journal of Pharmacology. 367(2-3). 351–359. 17 indexed citations
17.
Bonina, Francesco, Francesco Palagiano, Antonella Saija, et al.. (1999). Synthesis, stability, and pharmacological evaluation of nipecotic acid prodrugs. Journal of Pharmaceutical Sciences. 88(5). 561–567. 61 indexed citations
18.
Nava, Felice, et al.. (1997). Melatonin effects on inhibition of thirst and fever induced by lipopolysaccharide in rat. European Journal of Pharmacology. 331(2-3). 267–274. 49 indexed citations
19.
Nava, Felice, et al.. (1997). Effects of interleukin-10 on water intake, locomotory activity, and rectal temperature in rat treated with endotoxin. International Journal of Immunopharmacology. 19(1). 31–38. 52 indexed citations
20.
Sarro, A. De, Silvana Grasso, Maria Zappalà, Felice Nava, & Giovambattista De Sarro. (1997). Convulsant effects of some xanthine derivatives in genetically epilepsy-prone rats. Naunyn-Schmiedeberg s Archives of Pharmacology. 356(1). 48–55. 35 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026